A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefits-Reference-Cited by-同舟云学术

A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefits

Published:2014-08-07 Issue:1 Volume:15 Page:
ISSN:2050-6511
Container-title:BMC Pharmacology and Toxicology
language:en
Short-container-title:BMC Pharmacol Toxicol

Author:

Anil Tharappel M,Dandu Anilkumar,Harsha KrishnaReddy,Singh Jaideep,Shree Nitya,Kumar Venkatesh Satish,Lakshmi Mudigere N,Sunil Venkategowda,Harish Chandrashekaran,Balamurali Gundalmandikal V,Naveen Kumar Baisani S,Gopala Aralakuppe S,Pratibha Shivakumar,Sadasivuni ManojKumar,Anup Mammen O,Moolemath Yoganand,Venkataranganna Marikunte V,Jagannath Madanahalli R,Somesh Baggavalli P

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1186/2050-6511-15-43.pdf

Reference59 articles.

1. Hadoke PWF, Iqbal J, Walker BR: Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease. Br J Pharmacol. 2009, 156 (5): 689-712.

2. Friedman TC, Mastorakos G, Newman TD, Mullen NM, Horton EG, Costello R, Papadopoulos NM, Chrousos GP: Carbohydrate and lipid metabolism in endogenous hypercortisolism: shared features with metabolic syndrome X and NIDDM. Endocr J. 1996, 43 (6): 645-655.

3. Stewart PM, Krozowski ZS: 11 beta-Hydroxysteroid dehydrogenase. Vitam Horm. 1999, 57: 249-324.

4. Ricketts ML, Verhaeg JM, Bujalska I, Howie AJ, Rainey WE, Stewart PM: Immunohistochemical localization of type 1 11beta-hydroxysteroid dehydrogenase in human tissues. J Clin Endocrinol Metab. 1998, 83: 1325-1335.

5. Whorwood CB, Mason JI, Ricketts ML, Howie AJ, Stewart PM: Detection of human 11 beta-hydroxysteroid dehydrogenase isoforms using reverse-transcriptase-polymerase chain reaction and localization of the type 2 isoform to renal collecting ducts. Mol Cell Endocrinol. 1995, 110 (1–2): R7-R12.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EJE Prize 2023: genes on steroids—genomic control of hepatic metabolism by the glucocorticoid receptor;European Journal of Endocrinology;2023-04-29

2. Discovery of novel inhibitor of 11 beta-hydroxysteroid dehydrogenase type 1 using in silico structure-based screening approach for the treatment of type 2 diabetes;Journal of Diabetes & Metabolic Disorders;2023-03-06

3. Celastrol attenuates high‐fructose diet‐induced inflammation and insulin resistance via inhibition of 11β‐hydroxysteroid dehydrogenase type 1 activity in rat adipose tissues;BioFactors;2021-10-21

4. An Open-label Phase I/IIa Clinical Trial of 11β-HSD1 Inhibitor for Cushing’s Syndrome and Autonomous Cortisol Secretion;The Journal of Clinical Endocrinology & Metabolism;2021-06-18

5. Molecular Mechanisms of Glucocorticoid-Induced Insulin Resistance;International Journal of Molecular Sciences;2021-01-09